Pierik M - Search Results

1

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L, Pierik M, Hlavaty T, Van Assche G, Noman M, Rutgeerts P. Persoons P, et al. Among authors: pierik m. Aliment Pharmacol Ther. 2005 Jul 15;22(2):101-10. doi: 10.1111/j.1365-2036.2005.02535.x. Aliment Pharmacol Ther. 2005. PMID: 16011668 Free article.

2

Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis.

Vermeire S, Rutgeerts P, Van Steen K, Joossens S, Claessens G, Pierik M, Peeters M, Vlietinck R. Vermeire S, et al. Among authors: pierik m. Gut. 2004 Jul;53(7):980-6. doi: 10.1136/gut.2003.034033. Gut. 2004. PMID: 15194648 Free PMC article.

3

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.

Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Devière J, Rutgeerts P. Franchimont D, et al. Among authors: pierik m. Gut. 2004 Jul;53(7):987-92. doi: 10.1136/gut.2003.030205. Gut. 2004. PMID: 15194649 Free PMC article.

4

Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.

Pierik M, Vermeire S, Steen KV, Joossens S, Claessens G, Vlietinck R, Rutgeerts P. Pierik M, et al. Aliment Pharmacol Ther. 2004 Aug 1;20(3):303-10. doi: 10.1111/j.1365-2036.2004.01946.x. Aliment Pharmacol Ther. 2004. PMID: 15274667 Free article.

5

Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease.

Pierik M, De Hertogh G, Vermeire S, Van Assche G, Van Eyken P, Joossens S, Claessens G, Vlietinck R, Rutgeerts P, Geboes K. Pierik M, et al. Gut. 2005 Feb;54(2):223-7. doi: 10.1136/gut.2004.042572. Gut. 2005. PMID: 15647186 Free PMC article.

6

Crohn's disease and month of birth.

Van Ranst M, Joossens M, Joossens S, Van Steen K, Pierik M, Vermeire S, Rutgeerts P. Van Ranst M, et al. Among authors: pierik m. Inflamm Bowel Dis. 2005 Jun;11(6):597-9. doi: 10.1097/01.mib.0000163697.34592.d4. Inflamm Bowel Dis. 2005. PMID: 15905708

7

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.

Hlavaty T, Pierik M, Henckaerts L, Ferrante M, Joossens S, van Schuerbeek N, Noman M, Rutgeerts P, Vermeire S. Hlavaty T, et al. Among authors: pierik m. Aliment Pharmacol Ther. 2005 Oct 1;22(7):613-26. doi: 10.1111/j.1365-2036.2005.02635.x. Aliment Pharmacol Ther. 2005. PMID: 16181301 Free article.

8

Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease.

Joossens S, Pierik M, Rector A, Vermeire S, Ranst MV, Rutgeerts P, Bossuyt X. Joossens S, et al. Among authors: pierik m. Gut. 2006 May;55(5):746. doi: 10.1136/gut.2005.089136. Gut. 2006. PMID: 16609142 Free PMC article. No abstract available.

9

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

D'Haens G, Vermeire S, Lambrecht G, Baert F, Bossuyt P, Pariente B, Buisson A, Bouhnik Y, Filippi J, Vander Woude J, Van Hootegem P, Moreau J, Louis E, Franchimont D, De Vos M, Mana F, Peyrin-Biroulet L, Brixi H, Allez M, Caenepeel P, Aubourg A, Oldenburg B, Pierik M, Gils A, Chevret S, Laharie D; GETAID. D'Haens G, et al. Among authors: pierik m. Gastroenterology. 2018 Apr;154(5):1343-1351.e1. doi: 10.1053/j.gastro.2018.01.004. Epub 2018 Jan 6. Gastroenterology. 2018. PMID: 29317275 Free article. Clinical Trial.

10

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.

Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH; Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC). Simsek M, et al. Among authors: pierik m. Aliment Pharmacol Ther. 2019 May;49(10):1293-1300. doi: 10.1111/apt.15229. Epub 2019 Mar 25. Aliment Pharmacol Ther. 2019. PMID: 30908719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page